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A B S T R A C T To determine whether pituitary thyrotropin (TSH) responsiveness to thyrotropin-releasing hormone (TRH) is enhanced by small decreases in serum thyroxine (To) and triiodothyronine (Ti), 12 euthyroid volunteers were given 190 mg iodide po daily for 10 days to inhibit T4 and Tt release from the thyroid. Basal serum To, T3, and TSH concentrations and the serum T4 and TSH responses to 400 iug TRH i.v. were assessed before and at the end of iodide administration. Iodide induced small but highly significant decreases in basal serum To (8.0±1.6 vs. 6 .6±1.7 ug/lOO ml; mean + SD) and T3 (128±15 vs. 110±22 ng/100 ml) and increases in basal serum TSH (1.3±0.9 vs. 2.1±1.0 gU/ ml). During iodide administration, the TSH response to TRH was significantly increased at each of seven time points up to 120 min. The maximum increment in serum TSH after TRH increased from a control mean of 8.8± 4.1 to a mean of 13.0+2.8 ALU/ml during iodide administration. As evidence of the inhibitory effect of iodide on hormonal release, the increment in serum Ts at 120 min after TRH was significantly lessened during iodide administration (61±42 vs. 33±24 ng/100 ml). These postulate that such suppression reflects secretion by the nodule of precisely physiological quantities of hormone, rather than a slight excess. Thus, it is evident that the set point of feedback regulation is tuned to detect not only gross, but also subtle, increases in the availability of thyroid hormones. It also seems clear that regulatory mechanisms within the pituitary are capable of detecting rather subtle deficiencies in the availability of thyroid hormones, but little is known of the rapidity of such response. One factor that has hampered studies of this topic is that a predictable means of producing acute small decreases in the supply of thyroid hormones in euthyroid individuals has not been apparent. Recently, however, we have demonstrated that pharmacological doses of iodide produce in normal individuals a slight decrease in serum T and Ts concentrations that is evident within a few days (12) .
In this report we describe the effects of such treatment on the intrapituitary regulatory response, as judged from the rise in serum TSH after synthetic TRH administration.
METHODS
Studies were performed in nine male and three female normal volunteers ranging in age between 23 and 35 yr. During a control period, blood was obtained daily from each subject between 9:00 and 11:00 a.m. for 3 consecutive days. On the 3rd day, samples of blood were obtained 10 min before and immediately before an i.v. pulse injection of 400 ,ug synthetic TRH, as well as 10, 20, 30, 45, 60, 90, and 120 min thereafter. Subjects were then given five drops of Lyne's saturated solution of potassium iodide twice daily (190 mg iodide daily) for 10 days. Blood was drawn in the morning on the last 3 days of iodide administration, and on the last (10th) day another TRH test was done, as described above. Sera were quickly obtained from the foregoing samples of blood and were stored frozen at -20'C until required for analyses. Serum T. concentration was measured by the Tetralute method (Ames Co., Div. of Miles Lab, Inc., Elkhart, Ind.) (13) , and serum Ts concentration by radioimmunoassay using 8-anilino-l-naphthalene sulfonic acid to inhibit binding of Ts to plasma proteins. Charcoal coated with bovine serum albumin was used to separate bound from free hormone (14) . Serum TSH concentration was measured by a double antibody technique' (15 
RESULTS
All values for base-line serum T#, To, and TSH concentrations were normal during control periods, and although significantly altered during iodide administration, remained well within the normal range (Table I) . Base-line serum To and Ts concentrations. The serum To concentration decreased during iodide administration inl 11 of 12 -subjects, the mean value changing from 8.0±1.6 (mean SD) to 6.6±1.7 #g/100 ml (P < 0.001). The serum Ts concentration decreased in 10 subjects, remained unchanged in 1, and increased in another. In both of the latter subjects, a distinct decrease in the serum T4 concentration occurred during iodide administration. For the group as a whole, the mean serum Ta concentration decreased from 128±+15 to 110±22 ng/100 ml (P < 0.005).
Base-line serum TSH concentration. During the control period, base-line values for the serum TSH concentration were below the limit of detectability of the particular assay (0.6 or 1.3 XU/ml) in 8 of the 12 subjects. To make possible calculation of a mean value for the entire group, values in these eight subjects were taken to be equal to the value of this lower limit. By this method, the mean base-line serum TSH during the control period was calculated to be 1.3±0.9 XU/ml. During iodide administration, the base-line serum TSH concentration increased in eight subjects, remained undetectable in 2, unchanged in 1, and decreased in another, the mean value calculated as described above, increasing significantly to 2.1±f-1.0 /AU/ml (P <0.01). However-even during iodide administration, none -of -the values for basal serum TSH concentration exceeded the upper limit of the normal range (5 /AU/ml) as defined in this laboratory. - Serum TSH response to TRH (Table II) . During the control period,-the maximum increment in the serum TSH concentration after TRH administration averaged 8.8±4.1 --&U/ml (range 3.7-15.7). During iodide administration, the maximum increment in the serum TSH was greater than during the control test in 10 of 12 subjects, and was unchanged in 2. For the group as a whole, the maximum increment averaged 13.0±2.8 (range, 9.6-17.4), a significant increase from the control value (P < 0.005). This ificrease in the TRH response was evident at each time period after TRH administration studied (Fig. 1) .
Serum Ts response-to TRII (Table II) . The maximum increase in the serum Ts concentration that followed TRH administration was evident in -the 120-min samples in all subjects during the control period and in concentration. Moreover, some of the decrease in basal serum T3 concentration induced by iodides may reflect a shift in the relative rates of synthesis of T4 and Ts, favoring T4. Nagataki, Uchimura, Masuyama, Nakao, and Ito have demonstrated the T4/Ts ratio within thyroglobulin is higher in residents of Japan, who characteristically ingest a diet rich in iodide, than in residents of the United States (18) .
Despite a greater rise in serum TSH concentration, the increase in serum T3 concentration induced by TRH during iodide administration was less than during the control period. As with the lower basal serum T3 concentration seen during iodide administration, this could reflect either a general effect of iodide to inhibit hormone secretion or a shift in the T4/T3 ratio within the thyroid in favor of T4. Unfortunately, in the present studies, specimens of blood were not taken at a sufficiently long interval after administration of TRH to permit evaluation of the effect of iodide on the response of the serum T4 concentration, this being best assessed some 6 h after TRH is given (19). Hence, the extent to which iodides may have inhibited the TRH-induced secretion of T4 could not be evaluated.
Earlier studies have described a group of patients with underlying thyroid disease, be it Hashimoto's disease, simple goiter, or treated Graves's disease, who apparently have mild, compensated thyroid failure or "subclinical hypothyroidism" (20) (21) (22) (22) . The results of the present study go beyond this finding in two respects. First, the degree of hormone deficiency that iodides induced, though sufficient to increase basal serum TSH concentrations from control values, was not sufficient to bring them above the normal range. Second, the hormone deficiency which led to increased TRH responsiveness during iodide administration was of short duration, at most 10 days, while the deficit in patients with subclinical hypothyroidism is likely to have been chronic.
The subtlety of the decrease in thyroid hormone supply that enhances response to TRH, and the rapidity with which this change is manifest, suggests that increased responsiveness to TRH within the pituitary may be sufficient to explain the increased secretion of TSH seen in mild or compensated thyroid failure, and that increased secretion of TRH need not be invoked. This conclusion would accord with the fact that hypothalamic TRH content is normal in hypothyroid rats (23) . However, with respect to both mild and severe hypothyroidism in man, definitive conclusions concerning the relative roles of increased TRH secretion and enhanced pituitary responsiveness in augmenting TSH secretion must await the development of methods for measuring the rate of TRH secretion.
